Shukra Pharmaceuticals Stock Screener | Share Price & Fundamental Analysis
SHUKRAPHAR
Pharmaceuticals
Screen Shukra Pharmaceuticals share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹51.45
▼
-2.70 (-4.99%)
Market Cap
₹2,594.42 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
41.50
EPS (TTM)
₹0.22
Dividend Yield
0.02%
Debt to Equity
0.06
52W High
₹64.43
52W Low
₹12.09
Operating Margin
27.00%
Profit Margin
30.00%
Revenue (TTM)
₹40.00
EBITDA
₹17.00
Net Income
₹12.00
Total Assets
₹87.00
Total Equity
₹63.00
Shukra Pharmaceuticals Share Price History - Stock Screener Chart
Screen SHUKRAPHAR historical share price movements with interactive charts. Analyze price trends and patterns.
Shukra Pharmaceuticals Company Profile - Fundamental Screener
Screen Shukra Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SHUKRAPHAR shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE551C01044
Shukra Pharmaceuticals Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen SHUKRAPHAR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 87 | 78 | 75 | 35 | 36 | 34 | 28 | 24 | 19 | 17 |
| Current Assets | 65 | 56 | 53 | 16 | 16 | 15 | 11 | 8 | 7 | 6 |
| Fixed Assets | 19 | 20 | 20 | 18 | 18 | 17 | 16 | 14 | 10 | 10 |
| Liabilities | ||||||||||
| Total Liabilities | 87 | 78 | 75 | 35 | 36 | 34 | 28 | 24 | 19 | 17 |
| Current Liabilities | 7 | 6 | 7 | 6 | 13 | 11 | 9 | 6 | 3 | 3 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 63 | 58 | 25 | 16 | 16 | 15 | 15 | 15 | 15 | 14 |
| Share Capital | 44 | 11 | 4 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Reserves & Surplus | 19 | 47 | 21 | 15 | 14 | 14 | 14 | 13 | 13 | 13 |
Screen SHUKRAPHAR income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 40 | 37 | 77 | 60 | 21 | 12 | 12 | 6 | 6 | 5 | 5 | 4 |
| Expenses | 23 | 20 | 55 | 54 | 18 | 10 | 10 | 4 | 4 | 4 | 4 | 3 |
| EBITDA | 17 | 17 | 22 | 7 | 3 | 2 | 2 | 2 | 2 | 2 | 1 | 1 |
| Operating Profit % | 27.00% | 39.00% | 26.00% | 9.00% | 14.00% | 13.00% | 13.00% | 29.00% | 30.00% | 29.00% | 24.00% | -10.00% |
| Depreciation | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 1 |
| Interest | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 13 | 13 | 20 | 4 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 0 |
| Tax | 4 | 4 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Net Profit | 12 | 10 | 19 | 4 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 0 |
| EPS | 0.90 | 0.22 | 16.93 | 26.21 | 4.79 | 1.20 | 0.23 | 2.95 | 3.36 | 3.21 | 0.76 | 0.84 |
Shukra Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen SHUKRAPHAR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 8 | -5 | 3 | 8 | 1 | 1 | 0 | 1 | 0 | 3 |
| Investing Activities | -1 | -1 | -4 | -2 | -2 | -3 | -3 | -5 | -1 | 0 |
| Financing Activities | -5 | 12 | 5 | -7 | 2 | 2 | 2 | 4 | 0 | -1 |
| Net Cash Flow | 2 | 6 | 4 | 0 | 0 | 0 | 0 | -1 | -1 | 1 |
Screen SHUKRAPHAR shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 50.96% | 50.96% | 50.96% | 50.96% | 50.96% | 50.96% | 50.96% | 50.90% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 9.29% | 28.69% | 9.20% | 9.79% | 9.19% | 9.25% | 9.41% | 29.14% |
| Other Holding | 39.64% | 20.24% | 39.72% | 39.14% | 39.73% | 39.68% | 39.51% | 19.85% |
| Shareholder Count | 18,231 | 20,337 | 21,441 | 12,974 | 14,989 | 16,321 | 17,844 | 9,544 |
Shukra Pharmaceuticals Dividend Screener - Share Yield Analysis
Screen SHUKRAPHAR dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹0.01 | 0.02% |
| 2024-March | ₹1.00 | 4.58% |
| 2023-March | ₹0.50 | 6.13% |
| 2022-March | ₹0.50 | 42.74% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.50 | 208.33% |
| 2018-March | ₹0.50 | 263.16% |
| 2017-March | ₹0.50 | 156.25% |
| 2016-March | ₹0.00 | 0.00% |
Shukra Pharmaceuticals Index Membership - Market Screener Classification
Screen SHUKRAPHAR by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Shukra Pharmaceuticals Market Events Screener - Corporate Actions
Screen SHUKRAPHAR market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 0.01 /share | 126.55% | ||
| Dividend | ₹ 0.50 /share | 253.33% | ||
| Dividend | ₹ 1.00 /share | -40.51% | ||
| Annual General Meeting | NA | 5.63% | ||
| Dividend | ₹ 0.50 /share | 76.74% | ||
| Annual General Meeting | NA | 34.10% | ||
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -0.17% |
| 2025-11-01 | 2025-11-01 | Extraordinary General Meeting | NA | 19.04% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -9.76% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | -5.08% |
| 2025-03-21 | 2025-01-29 | Split | 1:10 | 0.00% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -9.64% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -6.35% |
| 2024-08-23 | 2024-08-23 | Extraordinary General Meeting | NA | -31.85% |
| 2024-04-19 | 2024-04-20 | Bonus | 3:1 | 12.62% |
Shukra Pharmaceuticals Competitors Screener - Peer Comparison
Screen SHUKRAPHAR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 412,950 | 39.35 | 54,729 | 9.71% | 10,980 | 39.06 |
| Divis Laboratories | 170,710 | 68.64 | 9,712 | 18.67% | 2,191 | 44.96 |
| Torrent Pharmaceuticals | 128,789 | 60.42 | 11,539 | 6.99% | 1,911 | 59.35 |
| Cipla | 120,673 | 22.17 | 28,410 | 7.12% | 5,291 | 42.76 |
| Dr Reddys Laboratories | 105,289 | 18.42 | 33,741 | 16.73% | 5,725 | 49.97 |
| Lupin | 95,151 | 21.87 | 22,910 | 13.74% | 3,306 | 50.10 |
| Zydus Life Science | 91,366 | 18.03 | 23,511 | 18.55% | 4,615 | 34.06 |
| Mankind Pharma | 89,434 | 50.11 | 12,744 | 20.90% | 2,007 | 40.67 |
| Aurobindo Pharma | 68,703 | 20.16 | 32,346 | 9.43% | 3,484 | 46.33 |
| Alkem Laboratories | 65,211 | 26.89 | 13,458 | 3.70% | 2,216 | 37.45 |
Shukra Pharmaceuticals Company Announcements - News Screener
Screen SHUKRAPHAR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-06 | Reconstitution Of Committees Of The Company. | View |
| 2026-01-06 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2026-01-06 | Announcement under Regulation 30 (LODR)-Resignation of Director | View |
| 2026-01-06 | Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Held On December 30 2025. | View |
| 2025-12-30 | Closure of Trading Window | View |
| 2025-12-29 | Intimation For Corporate Announcement Under Regulation 30 Of SEBI (LODR) Regulations Working In The Government Market Of Gujarat For Our Laparoscopic Sets And Accessories. | View |
| 2025-12-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-12-03 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | View |
| 2025-12-03 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2025-11-29 | Approval Of Continuation Of Directorship Of Mr. Jitendra Somchand Shah Non-Executive Independent Director Who Has Attained Age Of 75 Years On September 22 2025 Subject To Approval Of Shareholders. | View |
| 2025-11-29 | Outcome Of The Meeting Of The Board Of Directors Held On Saturday November 29 2025 | View |
| 2025-11-29 | Board Meeting Outcome for Outcome Of The Meetins Of The Board Of Directors Held On Saturdav. November 29.2025. | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-13 | Un-Audited Financial Results Of The Company For The Second Quarter And Half Year Ended September 30 2025 Along With The Auditors Limited Review Reports In Accordance With The Provisions Of Regulation 33 Of The SEBI Listing Regulations. | View |
| 2025-11-13 | Board Meeting Outcome for Outcome Of Board Meeting Held On November 13 2025. | View |
| 2025-11-10 | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Incorporation Of Subsidiary Company. | View |
| 2025-11-01 | Voting Result Along With Scrutinizer Report Of Extra Ordinary General Meeting (EOGM) Of The Company Held On November 01 2025. | View |
| 2025-11-01 | Shareholder Meeting / Postal Ballot-Outcome of EGM | View |
| 2025-10-31 | Board Meeting Intimation for Unaudited Financial Result For The Half Year Ended On 30TH September 2025 Along With The Auditors Limited Review Report. | View |
| 2025-10-31 | Receipt Of Distributorship Rights | View |